Russell Investments Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.7M | Sell |
95,214
-835
| -0.9% | -$162K | 0.02% | 672 |
|
|
2025
Q4 | $16.7M | Sell |
96,049
-3,828
| -4% | -$697K | 0.02% | 695 |
|
|
2025
Q3 | $19M | Buy |
99,877
+11,029
| +12% | +$1.96M | 0.02% | 639 |
|
|
2025
Q2 | $15.9M | Buy |
88,848
+25,768
| +41% | +$4.48M | 0.02% | 665 |
|
|
2025
Q1 | $10.7M | Sell |
63,080
-7,423
| -11% | -$1.22M | 0.01% | 795 |
|
|
2024
Q4 | $10.6M | Sell |
70,503
-4,276
| -6% | -$665K | 0.01% | 785 |
|
|
2024
Q3 | $11.6M | Sell |
74,779
-3,112
| -4% | -$465K | 0.02% | 777 |
|
|
2024
Q2 | $10.7M | Buy |
77,891
+3,501
| +5% | +$479K | 0.02% | 777 |
|
|
2024
Q1 | $9.88M | Sell |
74,390
-13,554
| -15% | -$1.76M | 0.02% | 835 |
|
|
2023
Q4 | $12.1M | Sell |
87,944
-3,879
| -4% | -$510K | 0.02% | 698 |
|
|
2023
Q3 | $11.2M | Sell |
91,823
-9,992
| -10% | -$1.33M | 0.02% | 703 |
|
|
2023
Q2 | $14.3M | Sell |
101,815
-6,696
| -6% | -$923K | 0.03% | 601 |
|
|
2023
Q1 | $15.3M | Sell |
108,511
-453
| -0.4% | -$64.8K | 0.03% | 610 |
|
|
2022
Q4 | $17.1M | Buy |
108,964
+13,344
| +14% | +$1.92M | 0.04% | 563 |
|
|
2022
Q3 | $11.7M | Buy |
95,620
+9,225
| +11% | +$1.21M | 0.03% | 687 |
|
|
2022
Q2 | $11.5M | Sell |
86,395
-9,611
| -10% | -$1.31M | 0.02% | 719 |
|
|
2022
Q1 | $13.2M | Sell |
96,006
-5,551
| -5% | -$774K | 0.02% | 715 |
|
|
2021
Q4 | $17.5M | Sell |
101,557
-11,109
| -10% | -$1.69M | 0.03% | 652 |
|
|
2021
Q3 | $16.4M | Sell |
112,666
-50,141
| -31% | -$7.34M | 0.03% | 671 |
|
|
2021
Q2 | $21.5M | Sell |
162,807
-74,703
| -31% | -$9.78M | 0.04% | 583 |
|
|
2021
Q1 | $30.5M | Buy |
237,510
+69,936
| +42% | +$8.62M | 0.05% | 413 |
|
|
2020
Q4 | $19.9M | Sell |
167,574
-52,399
| -24% | -$6.39M | 0.04% | 519 |
|
|
2020
Q3 | $25.1M | Sell |
219,973
-130,891
| -37% | -$15.5M | 0.05% | 394 |
|
|
2020
Q2 | $39.5M | Sell |
350,864
-165,777
| -32% | -$17.6M | 0.09% | 248 |
|
|
2020
Q1 | $41.9M | Buy |
516,641
+144,485
| +39% | +$15M | 0.11% | 215 |
|
|
2019
Q4 | $39.7M | Sell |
372,156
-62,124
| -14% | -$6.48M | 0.07% | 318 |
|
|
2019
Q3 | $46.3M | Sell |
434,280
-126,175
| -23% | -$13M | 0.09% | 272 |
|
|
2019
Q2 | $56.9M | Sell |
560,455
-588,779
| -51% | -$56.6M | 0.11% | 231 |
|
|
2019
Q1 | $103M | Buy |
1,149,234
+233,306
| +25% | +$20.2M | 0.19% | 111 |
|
|
2018
Q4 | $76.1M | Buy |
915,928
+400,988
| +78% | +$37.6M | 0.17% | 126 |
|
|
2018
Q3 | $55.5M | Sell |
514,940
-6,248
| -1% | -$685K | 0.11% | 203 |
|
|
2018
Q2 | $57.3M | Sell |
521,188
-87,904
| -14% | -$9.16M | 0.12% | 173 |
|
|
2018
Q1 | $61.1M | Sell |
609,092
-56,598
| -9% | -$5.8M | 0.1% | 227 |
|
|
2017
Q4 | $66M | Buy |
665,690
+112,849
| +20% | +$10.7M | 0.11% | 200 |
|
|
2017
Q3 | $51.8M | Sell |
552,841
-53,556
| -9% | -$5.69M | 0.09% | 272 |
|
|
2017
Q2 | $67.4M | Buy |
606,397
+67,706
| +13% | +$7.16M | 0.12% | 197 |
|
|
2017
Q1 | $52.9M | Buy |
538,691
+67,516
| +14% | +$6.44M | 0.1% | 246 |
|
|
2016
Q4 | $43.3M | Buy |
+471,175
| New | +$40.6M | 0.08% | 279 |
|
Other funds holding DGX
VCM
VPM
EIG
Russell Investments Group's DGX Position: Q1 2026 in Review
Russell Investments Group reduced its Quest Diagnostics (DGX) stake by 0.87% in Q1 2026, selling an estimated $162K and leaving 95,214 shares worth $18.7M. The position accounts for 0.02% of the portfolio, ranked #672.
Russell Investments Group first reported a position in DGX in Q4 2016 and has held it in 38 quarters since. The position peaked at $103M in Q1 2019. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Russell Investments Group held 95,214 shares of Quest Diagnostics worth $18.7M as of Q1 2026.
- Russell Investments Group sold 835 Quest Diagnostics shares in Q1 2026, an estimated $162K.
- Quest Diagnostics made up 0.02% of Russell Investments Group's portfolio in Q1 2026, its #672 holding.
- Russell Investments Group first reported a position in Quest Diagnostics in Q4 2016 and has held it in 38 quarters since.
- Russell Investments Group's Quest Diagnostics position peaked at $103M in Q1 2019.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.